Global and China Incretin-Based Drugs Market Insights, Forecast to 2026

Publisher Name :
Date: 11-Sep-2020
No. of pages: 129
Inquire Before Buying

Incretin-Based Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Incretin-Based Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Incretin-Based Drugs market is segmented into

- Glucagon-like peptide-1 receptor (GLP-1) agonists

- Dipeptidyl Peptidase-4 (DPP-4) inhibitors

Segment by Application, the Incretin-Based Drugs market is segmented into

- Oral Drugs

- Injectable Drugs

Regional and Country-level Analysis

The Incretin-Based Drugs market is analysed and market size information is provided by regions (countries).

The key regions covered in the Incretin-Based Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Incretin-Based Drugs Market Share Analysis

Incretin-Based Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Incretin-Based Drugs business, the date to enter into the Incretin-Based Drugs market, Incretin-Based Drugs product introduction, recent developments, etc.

The major vendors covered:

- GlaxoSmithKline

- Johnson & Johnson

- Merck & Co

- AstraZeneca

- Novartis

- Eli Lilly and Company

- Boehringer Ingelheim

- Takeda Pharmaceutical Company

- Sanofi

Global and China Incretin-Based Drugs Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Incretin-Based Drugs Product Introduction
1.2 Market Segments
1.3 Key Incretin-Based Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Incretin-Based Drugs Market Size Growth Rate by Type
1.4.2 Glucagon-like peptide-1 receptor (GLP-1) agonists
1.4.3 Dipeptidyl Peptidase-4 (DPP-4) inhibitors
1.5 Market by Application
1.5.1 Global Incretin-Based Drugs Market Size Growth Rate by Application
1.5.2 Oral Drugs
1.5.3 Injectable Drugs
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Incretin-Based Drugs Market Size, Estimates and Forecasts
2.1.1 Global Incretin-Based Drugs Revenue 2015-2026
2.1.2 Global Incretin-Based Drugs Sales 2015-2026
2.2 Global Incretin-Based Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Incretin-Based Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global Incretin-Based Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Incretin-Based Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Incretin-Based Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Incretin-Based Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global Incretin-Based Drugs Revenue Forecast by Region (2021-2026)
3 Global Incretin-Based Drugs Competitor Landscape by Players
3.1 Global Top Incretin-Based Drugs Sales by Manufacturers
3.1.1 Global Incretin-Based Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Incretin-Based Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global Incretin-Based Drugs Manufacturers by Revenue
3.2.1 Global Incretin-Based Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Incretin-Based Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Incretin-Based Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Incretin-Based Drugs Revenue in 2019
3.2.5 Global Incretin-Based Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Incretin-Based Drugs Price by Manufacturers
3.4 Global Incretin-Based Drugs Manufacturing Base Distribution, Product Types
3.4.1 Incretin-Based Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Incretin-Based Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Incretin-Based Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Incretin-Based Drugs Market Size by Type (2015-2020)
4.1.1 Global Incretin-Based Drugs Sales by Type (2015-2020)
4.1.2 Global Incretin-Based Drugs Revenue by Type (2015-2020)
4.1.3 Incretin-Based Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Incretin-Based Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Incretin-Based Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Incretin-Based Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Incretin-Based Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Incretin-Based Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Incretin-Based Drugs Market Size by Application (2015-2020)
5.1.1 Global Incretin-Based Drugs Sales by Application (2015-2020)
5.1.2 Global Incretin-Based Drugs Revenue by Application (2015-2020)
5.1.3 Incretin-Based Drugs Price by Application (2015-2020)
5.2 Incretin-Based Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Incretin-Based Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Incretin-Based Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Incretin-Based Drugs Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Incretin-Based Drugs Market Size YoY Growth 2015-2026
6.1.1 China Incretin-Based Drugs Sales YoY Growth 2015-2026
6.1.2 China Incretin-Based Drugs Revenue YoY Growth 2015-2026
6.1.3 China Incretin-Based Drugs Market Share in Global Market 2015-2026
6.2 China Incretin-Based Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Incretin-Based Drugs Players by Sales (2015-2020)
6.2.2 China Top Incretin-Based Drugs Players by Revenue (2015-2020)
6.3 China Incretin-Based Drugs Historic Market Review by Type (2015-2020)
6.3.1 China Incretin-Based Drugs Sales Market Share by Type (2015-2020)
6.3.2 China Incretin-Based Drugs Revenue Market Share by Type (2015-2020)
6.3.3 China Incretin-Based Drugs Price by Type (2015-2020)
6.4 China Incretin-Based Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Incretin-Based Drugs Sales Forecast by Type (2021-2026)
6.4.2 China Incretin-Based Drugs Revenue Forecast by Type (2021-2026)
6.4.3 China Incretin-Based Drugs Price Forecast by Type (2021-2026)
6.5 China Incretin-Based Drugs Historic Market Review by Application (2015-2020)
6.5.1 China Incretin-Based Drugs Sales Market Share by Application (2015-2020)
6.5.2 China Incretin-Based Drugs Revenue Market Share by Application (2015-2020)
6.5.3 China Incretin-Based Drugs Price by Application (2015-2020)
6.6 China Incretin-Based Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Incretin-Based Drugs Sales Forecast by Application (2021-2026)
6.6.2 China Incretin-Based Drugs Revenue Forecast by Application (2021-2026)
6.6.3 China Incretin-Based Drugs Price Forecast by Application (2021-2026)
7 North America
7.1 North America Incretin-Based Drugs Market Size YoY Growth 2015-2026
7.2 North America Incretin-Based Drugs Market Facts & Figures by Country
7.2.1 North America Incretin-Based Drugs Sales by Country (2015-2020)
7.2.2 North America Incretin-Based Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Incretin-Based Drugs Market Size YoY Growth 2015-2026
8.2 Europe Incretin-Based Drugs Market Facts & Figures by Country
8.2.1 Europe Incretin-Based Drugs Sales by Country
8.2.2 Europe Incretin-Based Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Incretin-Based Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific Incretin-Based Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific Incretin-Based Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific Incretin-Based Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Incretin-Based Drugs Market Size YoY Growth 2015-2026
10.2 Latin America Incretin-Based Drugs Market Facts & Figures by Country
10.2.1 Latin America Incretin-Based Drugs Sales by Country
10.2.2 Latin America Incretin-Based Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Incretin-Based Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Incretin-Based Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Incretin-Based Drugs Sales by Country
11.2.2 Middle East and Africa Incretin-Based Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Corporation Information
12.1.2 GlaxoSmithKline Description and Business Overview
12.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GlaxoSmithKline Incretin-Based Drugs Products Offered
12.1.5 GlaxoSmithKline Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Corporation Information
12.2.2 Johnson & Johnson Description and Business Overview
12.2.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Johnson & Johnson Incretin-Based Drugs Products Offered
12.2.5 Johnson & Johnson Recent Development
12.3 Merck & Co
12.3.1 Merck & Co Corporation Information
12.3.2 Merck & Co Description and Business Overview
12.3.3 Merck & Co Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck & Co Incretin-Based Drugs Products Offered
12.3.5 Merck & Co Recent Development
12.4 AstraZeneca
12.4.1 AstraZeneca Corporation Information
12.4.2 AstraZeneca Description and Business Overview
12.4.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
12.4.4 AstraZeneca Incretin-Based Drugs Products Offered
12.4.5 AstraZeneca Recent Development
12.5 Novartis
12.5.1 Novartis Corporation Information
12.5.2 Novartis Description and Business Overview
12.5.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Novartis Incretin-Based Drugs Products Offered
12.5.5 Novartis Recent Development
12.6 Eli Lilly and Company
12.6.1 Eli Lilly and Company Corporation Information
12.6.2 Eli Lilly and Company Description and Business Overview
12.6.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Eli Lilly and Company Incretin-Based Drugs Products Offered
12.6.5 Eli Lilly and Company Recent Development
12.7 Boehringer Ingelheim
12.7.1 Boehringer Ingelheim Corporation Information
12.7.2 Boehringer Ingelheim Description and Business Overview
12.7.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Boehringer Ingelheim Incretin-Based Drugs Products Offered
12.7.5 Boehringer Ingelheim Recent Development
12.8 Takeda Pharmaceutical Company
12.8.1 Takeda Pharmaceutical Company Corporation Information
12.8.2 Takeda Pharmaceutical Company Description and Business Overview
12.8.3 Takeda Pharmaceutical Company Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Takeda Pharmaceutical Company Incretin-Based Drugs Products Offered
12.8.5 Takeda Pharmaceutical Company Recent Development
12.9 Sanofi
12.9.1 Sanofi Corporation Information
12.9.2 Sanofi Description and Business Overview
12.9.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Sanofi Incretin-Based Drugs Products Offered
12.9.5 Sanofi Recent Development
12.11 GlaxoSmithKline
12.11.1 GlaxoSmithKline Corporation Information
12.11.2 GlaxoSmithKline Description and Business Overview
12.11.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.11.4 GlaxoSmithKline Incretin-Based Drugs Products Offered
12.11.5 GlaxoSmithKline Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Incretin-Based Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Incretin-Based Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Incretin-Based Drugs Market Segments
Table 2. Ranking of Global Top Incretin-Based Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Incretin-Based Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Glucagon-like peptide-1 receptor (GLP-1) agonists
Table 5. Major Manufacturers of Dipeptidyl Peptidase-4 (DPP-4) inhibitors
Table 6. Global Incretin-Based Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Incretin-Based Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Incretin-Based Drugs Sales by Regions 2015-2020 (K Units)
Table 9. Global Incretin-Based Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Incretin-Based Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Incretin-Based Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 12. Global Incretin-Based Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Incretin-Based Drugs Sales Share by Manufacturers (2015-2020)
Table 14. Global Incretin-Based Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Incretin-Based Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Incretin-Based Drugs as of 2019)
Table 16. Incretin-Based Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Incretin-Based Drugs Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Incretin-Based Drugs Price (2015-2020) (US$/Unit)
Table 19. Incretin-Based Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Incretin-Based Drugs Product Type
Table 21. Date of International Manufacturers Enter into Incretin-Based Drugs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Incretin-Based Drugs Sales by Type (2015-2020) (K Units)
Table 24. Global Incretin-Based Drugs Sales Share by Type (2015-2020)
Table 25. Global Incretin-Based Drugs Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Incretin-Based Drugs Revenue Share by Type (2015-2020)
Table 27. Incretin-Based Drugs Average Selling Price (ASP) by Type 2015-2020 (US$/Unit)
Table 28. Global Incretin-Based Drugs Sales Share by Type (2021-2026)
Table 29. Global Incretin-Based Drugs Sales by Application (2015-2020) (K Units)
Table 30. Global Incretin-Based Drugs Sales Share by Application (2015-2020)
Table 31. Global Incretin-Based Drugs Sales Share by Application (2021-2026)
Table 32. Global Incretin-Based Drugs Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Incretin-Based Drugs Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Incretin-Based Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 35. China Incretin-Based Drugs Sales (K Units) of Key Companies (2015-2020)
Table 36. China Incretin-Based Drugs Sales Share by Company (2015-2020)
Table 37. China Incretin-Based Drugs Revenue (US$ Million) by Company (2015-2020)
Table 38. China Incretin-Based Drugs Sales (K Units) by Type (2015-2020)
Table 39. China Incretin-Based Drugs Sales Share by Type (2015-2020)
Table 40. China Incretin-Based Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. China Incretin-Based Drugs Price (K Units) by Type (2015-2020)
Table 42. China Incretin-Based Drugs Sales (K Units) by Type (2021-2026)
Table 43. China Incretin-Based Drugs Sales Share by Type (2021-2026)
Table 44. China Incretin-Based Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. China Incretin-Based Drugs Revenue Share by Type (2021-2026)
Table 46. China Incretin-Based Drugs Price (K Units) by Type (2021-2026)
Table 47. China Incretin-Based Drugs Sales (K Units) by Application (2015-2020)
Table 48. China Incretin-Based Drugs Sales Share by Application (2015-2020)
Table 49. China Incretin-Based Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. China Incretin-Based Drugs Sales (K Units) by Application (2021-2026)
Table 51. China Incretin-Based Drugs Sales Share by Application (2021-2026)
Table 52. China Incretin-Based Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. China Incretin-Based Drugs Revenue Share by Application (2021-2026)
Table 54. North America Incretin-Based Drugs Sales by Country (2015-2020) (K Units)
Table 55. North America Incretin-Based Drugs Sales Market Share by Country (2015-2020)
Table 56. North America Incretin-Based Drugs Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Incretin-Based Drugs Revenue Market Share by Country (2015-2020)
Table 58. Europe Incretin-Based Drugs Sales by Country (2015-2020) (K Units)
Table 59. Europe Incretin-Based Drugs Sales Market Share by Country (2015-2020)
Table 60. Europe Incretin-Based Drugs Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Incretin-Based Drugs Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Incretin-Based Drugs Sales by Region (2015-2020) (K Units)
Table 63. Asia Pacific Incretin-Based Drugs Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Incretin-Based Drugs Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Incretin-Based Drugs Revenue Market Share by Region (2015-2020)
Table 66. Latin America Incretin-Based Drugs Sales by Country (2015-2020) (K Units)
Table 67. Latin America Incretin-Based Drugs Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Incretin-Based Drugs Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Incretin-Based Drugs Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Incretin-Based Drugs Sales by Country (2015-2020) (K Units)
Table 71. Middle East and Africa Incretin-Based Drugs Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Incretin-Based Drugs Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Incretin-Based Drugs Revenue Market Share by Country (2015-2020)
Table 74. GlaxoSmithKline Corporation Information
Table 75. GlaxoSmithKline Description and Business Overview
Table 76. GlaxoSmithKline Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 77. GlaxoSmithKline Incretin-Based Drugs Product
Table 78. GlaxoSmithKline Recent Development
Table 79. Johnson & Johnson Corporation Information
Table 80. Johnson & Johnson Description and Business Overview
Table 81. Johnson & Johnson Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 82. Johnson & Johnson Product
Table 83. Johnson & Johnson Recent Development
Table 84. Merck & Co Corporation Information
Table 85. Merck & Co Description and Business Overview
Table 86. Merck & Co Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 87. Merck & Co Product
Table 88. Merck & Co Recent Development
Table 89. AstraZeneca Corporation Information
Table 90. AstraZeneca Description and Business Overview
Table 91. AstraZeneca Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 92. AstraZeneca Product
Table 93. AstraZeneca Recent Development
Table 94. Novartis Corporation Information
Table 95. Novartis Description and Business Overview
Table 96. Novartis Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 97. Novartis Product
Table 98. Novartis Recent Development
Table 99. Eli Lilly and Company Corporation Information
Table 100. Eli Lilly and Company Description and Business Overview
Table 101. Eli Lilly and Company Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 102. Eli Lilly and Company Product
Table 103. Eli Lilly and Company Recent Development
Table 104. Boehringer Ingelheim Corporation Information
Table 105. Boehringer Ingelheim Description and Business Overview
Table 106. Boehringer Ingelheim Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 107. Boehringer Ingelheim Product
Table 108. Boehringer Ingelheim Recent Development
Table 109. Takeda Pharmaceutical Company Corporation Information
Table 110. Takeda Pharmaceutical Company Description and Business Overview
Table 111. Takeda Pharmaceutical Company Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 112. Takeda Pharmaceutical Company Product
Table 113. Takeda Pharmaceutical Company Recent Development
Table 114. Sanofi Corporation Information
Table 115. Sanofi Description and Business Overview
Table 116. Sanofi Incretin-Based Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 117. Sanofi Product
Table 118. Sanofi Recent Development
Table 119. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 120. Key Challenges
Table 121. Market Risks
Table 122. Main Points Interviewed from Key Incretin-Based Drugs Players
Table 123. Incretin-Based Drugs Customers List
Table 124. Incretin-Based Drugs Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Incretin-Based Drugs Product Picture
Figure 2. Global Incretin-Based Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Glucagon-like peptide-1 receptor (GLP-1) agonists Product Picture
Figure 4. Dipeptidyl Peptidase-4 (DPP-4) inhibitors Product Picture
Figure 5. Global Incretin-Based Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Oral Drugs
Figure 7. Injectable Drugs
Figure 8. Incretin-Based Drugs Report Years Considered
Figure 9. Global Incretin-Based Drugs Market Size 2015-2026 (US$ Million)
Figure 10. Global Incretin-Based Drugs Sales 2015-2026 (K Units)
Figure 11. Global Incretin-Based Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Incretin-Based Drugs Sales Market Share by Region (2015-2020)
Figure 13. Global Incretin-Based Drugs Sales Market Share by Region in 2019
Figure 14. Global Incretin-Based Drugs Revenue Market Share by Region (2015-2020)
Figure 15. Global Incretin-Based Drugs Revenue Market Share by Region in 2019
Figure 16. Global Incretin-Based Drugs Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Incretin-Based Drugs Revenue in 2019
Figure 18. Incretin-Based Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Incretin-Based Drugs Sales Market Share by Type (2015-2020)
Figure 20. Global Incretin-Based Drugs Sales Market Share by Type in 2019
Figure 21. Global Incretin-Based Drugs Revenue Market Share by Type (2015-2020)
Figure 22. Global Incretin-Based Drugs Revenue Market Share by Type in 2019
Figure 23. Global Incretin-Based Drugs Market Share by Price Range (2015-2020)
Figure 24. Global Incretin-Based Drugs Sales Market Share by Application (2015-2020)
Figure 25. Global Incretin-Based Drugs Sales Market Share by Application in 2019
Figure 26. Global Incretin-Based Drugs Revenue Market Share by Application (2015-2020)
Figure 27. Global Incretin-Based Drugs Revenue Market Share by Application in 2019
Figure 28. China Incretin-Based Drugs Sales Growth Rate 2015-2026 (K Units)
Figure 29. China Incretin-Based Drugs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 30. China Incretin-Based Drugs Market Share in Global Market 2015-2026
Figure 31. China 5 and 10 Largest Incretin-Based Drugs Players Market Share by Revenue in Incretin-Based Drugs in 2019
Figure 32. China Incretin-Based Drugs Revenue Share by Type (2015-2020)
Figure 33. China Incretin-Based Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 34. China Incretin-Based Drugs Revenue Share by Application (2015-2020)
Figure 35. China Incretin-Based Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 36. North America Incretin-Based Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 37. North America Incretin-Based Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America Incretin-Based Drugs Sales Market Share by Country in 2019
Figure 39. North America Incretin-Based Drugs Revenue Market Share by Country in 2019
Figure 40. U.S. Incretin-Based Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 41. U.S. Incretin-Based Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada Incretin-Based Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 43. Canada Incretin-Based Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Europe Incretin-Based Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 45. Europe Incretin-Based Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Incretin-Based Drugs Sales Market Share by Country in 2019
Figure 47. Europe Incretin-Based Drugs Revenue Market Share by Country in 2019
Figure 48. Germany Incretin-Based Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. Germany Incretin-Based Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Incretin-Based Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. France Incretin-Based Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Incretin-Based Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. U.K. Incretin-Based Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Incretin-Based Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 55. Italy Incretin-Based Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Incretin-Based Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 57. Russia Incretin-Based Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Asia Pacific Incretin-Based Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific Incretin-Based Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Incretin-Based Drugs Sales Market Share by Region in 2019
Figure 61. Asia Pacific Incretin-Based Drugs Revenue Market Share by Region in 2019
Figure 62. China Incretin-Based Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 63. China Incretin-Based Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Incretin-Based Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan Incretin-Based Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Incretin-Based Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea Incretin-Based Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Incretin-Based Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. India Incretin-Based Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Incretin-Based Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia Incretin-Based Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Incretin-Based Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan Incretin-Based Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Incretin-Based Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia Incretin-Based Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Incretin-Based Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand Incretin-Based Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Incretin-Based Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. Malaysia Incretin-Based Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Incretin-Based Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 81. Philippines Incretin-Based Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Incretin-Based Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 83. Vietnam Incretin-Based Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Latin America Incretin-Based Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Incretin-Based Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Incretin-Based Drugs Sales Market Share by Country in 2019
Figure 87. Latin America Incretin-Based Drugs Revenue Market Share by Country in 2019
Figure 88. Mexico Incretin-Based Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Incretin-Based Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Incretin-Based Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Incretin-Based Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Incretin-Based Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Incretin-Based Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Middle East and Africa Incretin-Based Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 95. Middle East and Africa Incretin-Based Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Incretin-Based Drugs Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Incretin-Based Drugs Revenue Market Share by Country in 2019
Figure 98. Turkey Incretin-Based Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 99. Turkey Incretin-Based Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Incretin-Based Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 101. Saudi Arabia Incretin-Based Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. UAE Incretin-Based Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 103. UAE Incretin-Based Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Porter's Five Forces Analysis
Figure 105. Incretin-Based Drugs Value Chain
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Bottom-up and Top-down Approaches for This Report
Figure 109. Data Triangulation
Figure 110. Key Executives Interviewed
  • (COVID-19 Version) Global Metformin Hydrochloride Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 22-Oct-2020        Price: US 3000 Onwards        Pages: 90
    Summary The report forecast global Metformin Hydrochloride market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Metformin Hydrochloride industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Metformin Hydrochlor......
  • Global Antidiabetic Biguanides Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 22-Oct-2020        Price: US 3400 Onwards        Pages: 119
    The Antidiabetic Biguanides market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Antidiabetic Biguanides market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Antidiabetic Biguanides market. The report focuses on well-known providers in the global Antidiabetic Biguanides industry, market segments, ......
  • Global Diabetic Therapeutic Drugs Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 22-Oct-2020        Price: US 3400 Onwards        Pages: 124
    The Diabetic Therapeutic Drugs market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Diabetic Therapeutic Drugs market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Diabetic Therapeutic Drugs market. The report focuses on well-known providers in the global Diabetic Therapeutic Drugs industry, marke......
  • Global Antidiabetic Thiazolidinediones Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 20-Oct-2020        Price: US 3400 Onwards        Pages: 129
    The Antidiabetic Thiazolidinediones market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Antidiabetic Thiazolidinediones market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Antidiabetic Thiazolidinediones market. The report focuses on well-known providers in the global Antidiabetic Thiazolidinedi......
  • Global Liraglutide Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 13-Oct-2020        Price: US 3400 Onwards        Pages: 119
    The Liraglutide market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Liraglutide market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Liraglutide market. The report focuses on well-known providers in the global Liraglutide industry, market segments, competition, and the macro environment. ......
  • Global Acarbose Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 13-Oct-2020        Price: US 3400 Onwards        Pages: 115
    The Acarbose market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Acarbose market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Acarbose market. The report focuses on well-known providers in the global Acarbose industry, market segments, competition, and the macro environment. Under......
  • COVID-19 World Insulin API Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 08-Oct-2020        Price: US 2800 Onwards        Pages: 92
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Insulin API , covering Global total and ......
  • Global Human Insulin Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 08-Oct-2020        Price: US 3400 Onwards        Pages: 124
    The Human Insulin market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Human Insulin market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Human Insulin market. The report focuses on well-known providers in the global Human Insulin industry, market segments, competition, and the macro environment.......
  • (COVID-19 Version) Global Lixisenatide Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 07-Oct-2020        Price: US 3000 Onwards        Pages: 95
    Summary The report forecast global Lixisenatide market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Lixisenatide industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Lixisenatide by geography. The report spli......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs